Company Performance Metrics
Elastin Biosciences is a spin-out of Longaevus Technologies developing an “Elastin Restoration” platform to reverse extracellular-matrix deterioration – an overlooked but fundamental driver of aging. Its proprietary therapeutics are designed to both block elastin degradation and promote new elastin synthesis in key tissues, including blood vessels,
lungs, and skin. By targeting structural decline at its source, the company is at the frontier of health-span and longevity therapeutics, with applications spanning rare elastin-deficiency syndromes to widespread age-related degeneration.